Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in Cardiovasc Res Retrieve available abstracts of 36 articles: HTML format

Single Articles

April 2025
1. AHMAD H, Gopakumar J, Nachun DC, Ma L, et al
   Single cell RNA sequencing of haematopoietic cells in fresh and frozen human atheroma tissue.
   Cardiovasc Res. 2025;121:396-404.
   PubMed     Abstract available
   
   
   
2. BONACINA F, Carnevale D
   Sleep protects the heart after myocardial infarction through a neuro-immune axis: time to implement healthy sleep for cardiovascular prevention?
   Cardiovasc Res. 2025 Apr 23:cvaf073. doi: 10.1093.
   PubMed    
   
   
   
3. DARWESH AM, Fang L, Altamimi TR, Jamieson KL, et al
   Cardioprotective effect of 19,20-epoxydocosapentaenoic acid (19,20-EDP) in ischaemic injury involves direct activation of mitochondrial sirtuin 3.
   Cardiovasc Res. 2025;121:267-282.
   PubMed     Abstract available
   
   
   
4. ZHANG W, Zhang Y, Han L, Bo T, et al
   Double-stranded DNA enhances platelet activation, thrombosis, and myocardial injury via cyclic GMP-AMP synthase.
   Cardiovasc Res. 2025;121:353-366.
   PubMed     Abstract available
   
   
   
5. ROSLAN A, Paulus K, Yang J, Matt L, et al
   Slack K+ channels confer protection against myocardial ischaemia/reperfusion injury.
   Cardiovasc Res. 2025;121:174-189.
   PubMed     Abstract available
   
   
   
6. DALKARA T, Ostergaard L, Heusch G, Attwell D, et al
   Pericytes in the brain and heart: functional roles and response to ischaemia and reperfusion.
   Cardiovasc Res. 2025;120:2336-2348.
   PubMed     Abstract available
   
   
   February 2025
7. CHEN M, Zhao N, Shi W, Xing Y, et al
   Glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist tirzepatide promotes branched chain amino acid catabolism to prevent myocardial infarction in non-diabetic mice.
   Cardiovasc Res. 2025 Feb 10:cvaf005. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. SHANG R, Rodrigues B
   Cardioprotective effects of a 'twincretin' drug tirzepatide in heart failure following myocardial infarction.
   Cardiovasc Res. 2025 Feb 4:cvaf006. doi: 10.1093.
   PubMed    
   
   
   January 2025
9. VILAHUR G, Ben-Aicha S, Gutierrez M, Radike M, et al
   Cardioprotection exerted by intravenous statin at index myocardial infarction event attenuates cardiac damage upon recurrent infarction.
   Cardiovasc Res. 2025 Jan 3:cvae264. doi: 10.1093.
   PubMed     Abstract available
   
   
   December 2024
10. FABIN N, Cenko E, Bergami M, Yoon J, et al
    Early coronary revascularization among 'stable' patients with non-ST-segment elevation acute coronary syndromes: the role of diabetes and age.
    Cardiovasc Res. 2024;120:2064-2077.
    PubMed     Abstract available
    
    
    
11. TANG XL, Wysoczynski M, Gumpert AM, Solanki M, et al
    Intravenous infusions of mesenchymal stromal cells have cumulative beneficial effects in a porcine model of chronic ischaemic cardiomyopathy.
    Cardiovasc Res. 2024;120:1939-1952.
    PubMed     Abstract available
    
    
    
12. TAN J, Min J, Jiang Y, Liu S, et al
    CircCHSY1 protects hearts against ischaemia/reperfusion injury by enhancing heme oxygenase 1 expression via miR-24-3p.
    Cardiovasc Res. 2024;120:1924-1938.
    PubMed     Abstract available
    
    
    November 2024
13. AHERRAHROU R, Reinberger T, Hashmi S, Erdmann J, et al
    GWAS breakthroughs: mapping the journey from one locus to 393 significant coronary artery disease associations.
    Cardiovasc Res. 2024;120:1508-1530.
    PubMed     Abstract available
    
    
    
14. PAN Z, Lv J, Zhao L, Xing K, et al
    CircARCN1 aggravates atherosclerosis by regulating HuR-mediated USP31 mRNA in macrophages.
    Cardiovasc Res. 2024;120:1531-1549.
    PubMed     Abstract available
    
    
    
15. ZHANG LJ, Hu YX, Huang RZ, Xu YY, et al
    Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition.
    Cardiovasc Res. 2024;120:1622-1635.
    PubMed     Abstract available
    
    
    October 2024
16. WANG YJ, Matter CM
    Histone deacetylase 6 suppression protects from myocardial ischaemia-reperfusion injury in diabetes: insights from genetic deletion and pharmacological inhibition.
    Cardiovasc Res. 2024;120:1369-1371.
    PubMed    
    
    
    
17. BAUMGARDT SL, Fang J, Fu X, Liu Y, et al
    Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes.
    Cardiovasc Res. 2024;120:1456-1471.
    PubMed     Abstract available
    
    
    September 2024
18. YANG R, Ruan B, Wang R, Zhang X, et al
    Cardiomyocyte betaII spectrin plays a critical role in maintaining cardiac function by regulating mitochondrial respiratory function.
    Cardiovasc Res. 2024;120:1312-1326.
    PubMed     Abstract available
    
    
    
19. HEIANZA Y, Wang X, Kou M, Tiwari S, et al
    Circulating dimethylguanidino valeric acid, dietary factors, and risk of coronary heart disease.
    Cardiovasc Res. 2024 Sep 7:cvae199. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2024
20. PSALTIS PJ, Nguyen MT, Singh K, Sinhal A, et al
    Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction.
    Cardiovasc Res. 2024 Aug 27:cvae191. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. VAN OORTMERSSEN JAE, Ntlapo N, Tilly MJ, Bramer WM, et al
    Burden of risk factors in women and men with unrecognised myocardial infarction: a systematic review and meta-analysis.
    Cardiovasc Res. 2024 Aug 27:cvae188. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2024
22. HU M, Zhang X, Hu C, Ma ZG, et al
    Isthmin-1 alleviates cardiac ischaemia/reperfusion injury through cGMP-PKG signalling pathway.
    Cardiovasc Res. 2024;120:1051-1064.
    PubMed     Abstract available
    
    
    
23. KUFAZVINEI TTJ, Chai J, Boden KA, Channon KM, et al
    Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes.
    Cardiovasc Res. 2024 Jul 19:cvae142. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. COLEMAN JA, Doste R, Ashkir Z, Coppini R, et al
    Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.
    Cardiovasc Res. 2024;120:914-926.
    PubMed     Abstract available
    
    
    
25. FU L, Du J, Furkert D, Shipton ML, et al
    Depleting inositol pyrophosphate 5-InsP7 protected the heart against ischaemia-reperfusion injury by elevating plasma adiponectin.
    Cardiovasc Res. 2024;120:954-970.
    PubMed     Abstract available
    
    
    June 2024
26. PHAM QH, Bui TVA, Sim WS, Lim KH, et al
    Daily oral administration of probiotics engineered to constantly secrete short-chain fatty acids effectively prevents myocardial injury from subsequent ischemic heart disease.
    Cardiovasc Res. 2024 Jun 8:cvae128. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. GRECO CM, Nisoli E
    The ketogenic diet is unable to improve cardiac function in ischemic heart failure: an unexpected result?
    Cardiovasc Res. 2024 Jun 6:cvae126. doi: 10.1093.
    PubMed    
    
    
    May 2024
28. SUGIYAMA T, Jang IK
    Is cutting-edge imaging technology superior to conventional angiography in improving outcomes of coronary artery stenting?
    Cardiovasc Res. 2024;120:e17-e19.
    PubMed    
    
    
    
29. HO KL, Karwi Q, Wang F, Wagg C, et al
    The ketogenic diet does not improve cardiac function and blunts glucose oxidation in ischemic heart failure.
    Cardiovasc Res. 2024 May 1:cvae092. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2024
30. MEHDIZADEH M, Naud P, Abu-Taha IH, Hiram R, et al
    The role of cellular senescence in profibrillatory atrial remodelling associated with cardiac pathology.
    Cardiovasc Res. 2024;120:506-518.
    PubMed     Abstract available
    
    
    
31. SUN Q, Chen W, Wu R, Tao B, et al
    Serine protease inhibitor, SerpinA3n regulates cardiac remodeling after myocardial infarction.
    Cardiovasc Res. 2024 Apr 26:cvae075. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2024
32. KIZER JR
    The elusive quest for causality in adiponectin's bimodal relationship with cardiovascular disease: Mendelian randomization meets Janus.
    Cardiovasc Res. 2024;120:3-5.
    PubMed    
    
    
    
33. DE WIT S, Geerlings L, Shi C, Dronkers J, et al
    Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice.
    Cardiovasc Res. 2024 Feb 24:cvae038. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. TORIMOTO K, Elliott K, Nakayama Y, Yanagisawa H, et al
    Cardiac and perivascular myofibroblasts, matrifibrocytes, and immune fibrocytes in hypertension; commonalities and differences with myocardial infarction and other cardiovascular diseases.
    Cardiovasc Res. 2024 Feb 23:cvae044. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2024
35. ABOULEISA RRE, Tang XL, Ou Q, Salama AM, et al
    Gene therapy encoding cell cycle factors to treat chronic ischemic heart failure in rats.
    Cardiovasc Res. 2024 Jan 4:cvae002. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2023
36. HIRAM R, Xiong F, Naud P, Xiao J, et al
    An inflammation resolution-promoting intervention prevents atrial fibrillation due to left-ventricular dysfunction.
    Cardiovasc Res. 2023 Dec 13:cvad175. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.